(Q86296609)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23466997%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

title

Cyst expansion and regression in a mouse model of polycystic kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23466997%20AND%20SRC:MED&resulttype=core&format=json

polycystic kidney disease

25 February 2020

main subject

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23466997%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Hester Happé

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23466997%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Annemieke M van der Wal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23466997%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Daniela C F Salvatori

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23466997%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Martijn H Breuning

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23466997%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Emile de Heer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23466997%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Dorien J M Peters

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23466997%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

language of work or name

English

0 references

publication date

6 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23466997%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23466997%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23466997%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23466997%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

page(s)

1099-1108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23466997%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.2013.13

25 February 2020

exact match

0 references

cites work

Autosomal dominant polycystic kidney disease--more than a renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Molecular basis of renal cyst formation--one hit or two?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Neonatal onset autosomal dominant polycystic kidney disease (ADPKD) in a patient homozygous for aPKD2missense mutation due to uniparental disomy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Renal histology in polycystic kidney disease with incipient and advanced renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Progressive renal fibrosis in murine polycystic kidney disease: an immunohistochemical observation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Polycystic kidney disease: Etiology, pathogenesis, and treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Pathogenic sequence for dissecting aneurysm formation in a hypomorphic polycystic kidney disease 1 mouse model

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. The European Polycystic Kidney Disease Consortium

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Overexpression of innate immune response genes in a model of recessive polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Polycystin 1 is required for the structural integrity of blood vessels

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Cardiac defects and renal failure in mice with targeted mutations in Pkd2

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Glomerular and proximal tubule cysts as early manifestations of Pkd1 deletion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Defining a link with autosomal-dominant polycystic kidney disease in mice with congenitally low expression of Pkd1

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Progressive renal distortion by multiple cysts in transgenic mice expressing artificial microRNAs against Pkd1

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Inhibition of autoregulated TGFbeta signaling simultaneously enhances proliferation and differentiation of kidney epithelium and promotes repair following renal ischemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Altered Hippo signalling in polycystic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Macrophages promote cyst growth in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Exploring the full spectrum of macrophage activation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Correlation of kidney function, volume and imaging findings, and PKHD1 mutations in 73 patients with autosomal recessive polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Apoptosis and loss of renal tissue in polycystic kidney diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Intermediate volume on computed tomography imaging defines a fibrotic compartment that predicts glomerular filtration rate decline in autosomal dominant polycystic kidney disease patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Polycystic kidney disease: neoplasia in disguise

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

mTOR inhibitors in polycystic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Sirolimus and kidney growth in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Everolimus in patients with autosomal dominant polycystic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021

Dose-dependent effects of sirolimus on mTOR signaling and polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.13

7 January 2021